logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
İ

İbrahim Vedat Bayoğlu

department of medical oncology
H指数:21
被引数:1,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

基线和早期治疗中的预后营养指数在激素受体阳性、HER2阴性转移性乳腺癌患者中的应用（接受CDK4/6抑制剂治疗）

Journal of Clinical Medicine
IF2.9
2026-09-020
OA
Ezgi Çoban; Atilla Eren Kurt; Fırat Akagündüz; Ahmet Demirel; Mustafa Alperen Tunç; Burak Paçacı; Ali Kaan Güren; Erkam Kocaaslan; Pınar Erel; Yeşim Ağyol; Abdussamet Çelebi; Selver Işık; Nazım Can Demircan; Osman Köstek; İbrahim Vedat Bayoğlu; Murat Sarı
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns

癌症患者数字健康参与度和健康素养：一项关于ICT使用模式的横断面研究

BMC Health Services Research
IF3
2026-08-210
OAAI
Abdussamet Çelebi; Nur Aybüke Bircan; Nadiye Sever; Ali Kaan Güren; Yeşim Ağyol; Erkam Kocaaslan; Pınar Erel; Burak Paçacı; Nargiz Majidova; Mustafa Alperen Tunç; Fırat Akagündüz; Ahmet Demirel; Selver Işık; Ezgi Çoban; Nazım Can Demircan; İbrahim Vedat Bayoğlu; Osman Köstek; Murat Sarı
Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Cohort Study

胰腺导管腺癌患者纵向体成分变化在FOLFIRINOX治疗中的分期特异性预后影响：一项双队列研究

Journal of Clinical Medicine
IF2.9
2026-08-140
OA
Ahmet Demirel; Bora İnceöz; Ali Kaan Güren; Burak Paçacı; Erkam Kocaaslan; Mustafa Alperen Tunç; Fırat Akagündüz; Emek Kaya; Canan Çimşit; Nazım Can Demircan; İbrahim Vedat Bayoğlu
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies

II期结肠癌的长期结局与条件无复发生存率：监测和复发检测策略的影响

Journal of Clinical Medicine
IF2.9
2026-06-240
OA
Mustafa Alperen Tunç; Ali Kaan Güren; Burak Paçacı; Fırat Akagündüz; Erkam Kocaaslan; Ahmet Demirel; Yeşim Ağyol; Pınar Erel; Nargiz Majidova; Nadiye Sever; Naz Tayyar Tunç; Nazım Can Demircan; Selver Işık; Abdussamed Çelebi; Ezgi Çoban; Osman Köstek; İbrahim Vedat Bayoğlu; Murat Sarı
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
Journal of Clinical Medicine
IF2.9
2026-01-260
OAAI
Erkam Kocaaslan; Ali Kaan Güren; Fırat Akagündüz; Ahmet Demirel; Mustafa Alperen Tunç; Burak Paçacı; Yeşim Ağyol; Pınar Erel; Abdüssamed Çelebi; Selver Işık; Ezgi Çoban; Nazım Can Demircan; Salih Özgüven; Zeynep Ceren Balaban Genç; Nargiz Majidova; Nadiye Sever; Murat Sarı; Osman Köstek; Ibrahim Vedat Bayoğlu
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab

接受尼鲁单抗治疗转移性非小细胞肺癌患者治疗相关体成分变化的预后价值

Medicina-Lithuania
IF2.4
2026-01-020
OAAI
Kocaaslan, Erkam; Guren, Ali Kaan; Akagunduz, Firat; Demirel, Ahmet; Tunc, Mustafa Alperen; Pacaci, Burak; Agyol, Yesim; Erel, Pinar; Celebi, Abdussamed; Isik, Selver; Coban, Ezgi; Demircan, Nazim Can; Ozguven, Salih; Balaban Genc, Zeynep Ceren; Majidova, Nargiz; Sever, Nadiye; Sari, Murat; Kostek, Osman; Bayoglu, Ibrahim Vedat
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

比较一线FOLFIRINOX与基于氟尿嘧啶和基于吉西他滨的化疗在转移性壶腹腺癌中的疗效：一项由土耳其肿瘤学组（TOG）进行的多中心研究

Journal of Clinical Medicine 2025, Vol. 14, Page 5868
IF2.9
2025-08-230
PRE
Ali Kalem; Tulay Kus; Savas Gokcek; Ilkay Tugba Unek; Taha Koray Sahin; Omer Dizdar; Muhammed Fatih Sagıroglu; Hatice Bolek; Yuksel Urun; Sendag Yaslıkaya; Ertugrul Bayram; Nadiye Sever; Ibrahim Vedat Bayoğlu; Omer Acar; Atike Pınar Erdogan; Seray Saray; Berkan Karabuga; Ulku Arslan Yalcıntas; Safa Can Efil; Mehmet Ali Nahit Sendur; Talat Aykut; Murat Araz; Tugce Kubra Gunes; Melike Ozcelik; Mustafa Seyyar; Gokmen Aktas; Suayib Yalcın
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)

FOLFIRINOX：胰腺导管腺癌的最佳辅助治疗？土耳其肿瘤学组（TOG）的多中心研究

Cancers 2025, Vol. 17, Page 2730
IF4.4
2025-08-220
PRE
Ali Kalem; Tulay Kus; Taha Koray Sahin; Omer Dizdar; Safa Can Efil; Mehmet Ali Nahit Sendur; Talat Aykut; Murat Araz; Hatice Bolek; Yuksel Urun; Nadiye Sever; Ibrahim Vedat Bayoglu; Eyyup Cavdar; Muhammed Fatih Sagıroglu; Tugce Kubra Gunes; Melike Ozcelik; Nadide Demirel; Bulent Yıldız; Berkan Karabuga; Ulku Yalcıntas Arslan; Savas Gokcek; Ilkay Tugba Unek; Seray Saray; Ferit Aslan; Omer Acar; Atike Pınar Erdogan; Mustafa Seyyar; Gokmen Aktas; Suayib Yalcın
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
JOURNAL OF CLINICAL MEDICINE
IF2.9
2025-03-170
OAAI
Sever, Nadiye; Simsek, Fatih; Onur, Ilknur Deliktas; Arvas, Hayati; Guliyev, Tural; Sakalar, Teoman; Cicek, Ceren Mordag; Orman, Seval; Cetin, Emine Bihter; Kayas, Kamil; Akbas, Sinem; Agyol, Yesim; Guren, Ali Kaan; Erel, Pinar; Kocaaslan, Erkam; Pacaci, Burak; Tunc, Mustafa Alperen; Celebi, Abdussamet; Majidova, Nargiz; Durnali, Ayse; Simsek, Melih; Sahbazlar, Mustafa; Isik, Selver; Arikan, Rukiye; Ercelep, Ozlem; Sari, Murat; Kostek, Osman; Bayogu, Ibrahim Vedat
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
JOURNAL OF CLINICAL MEDICINE
IF2.9
2025-02-070
OAAI
Guren, Ali Kaan; Guliyev, Murad; Alan, Ozkan; Cadirci, Kivanc; Belevi, Ipek Naz; Gulturk, Ilkay; Ozge, Emre; Kocaaslan, Erkam; Agyol, Yesim; Erel, Pinar; Pacaci, Burak; Tunc, Mustafa Alperen; Majidova, Nargiz; Sever, Nadiye; Celebi, Abdussamet; Arikan Erdogan, Rukiye; Isik, Selver; Demirci, Nebi Serkan; Sari, Murat; Kostek, Osman; Bayoglu, Ibrahim Vedat
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
SCIENTIFIC REPORTS
IF3.9
2024-11-300
OAAI
Sekmek, Serhat; Ozsan celebi, Sema Nur; Bayram, Dogan; Erol, Cihan; Kos, Fahriye Tugba; Sendur, Mehmet Ali Nahit; Altintas, Yunus Emre; Tuylu, Tugba; Yildirim, Sedat; Biter, Sedat; Kidi, Mehmet Mutlu; Bayram, Ertugrul; Majidova, Nargiz; Bayoglu, Ibrahim Vedat; Atak, Mehmetcan; Baskurt, Kadriye; Akbas, Sinem; Alkan, Ali; Bayramgil, Ayberk; Aslan, Ferit; Sahin, Elif; Balcik, Onur Yazdan; Bayhan, Ahmet Ziya; Saray, Seray; Arpaci, Erkan; Ergun, Yakup
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

瑞博西尼或帕博西尼联合来曲唑治疗激素受体阳性/HER2-negative转移性乳腺癌的疗效

FUTURE ONCOLOGY
IF2.6
2023-05-0310
PRE
Kahraman, Seda; Erul, Enes; Seyyar, Mustafa; Gumusay, Ozge; Bayram, Ertugrul; Demirel, Burcin Cakan; Acar, Omer; Aksoy, Sercan; Baytemur, Naziyet Kose; Sahin, Elif; Cabuk, Devrim; Basaran, Gul; Paydas, Semra; Yaren, Arzu; Guven, Deniz Can; Erdogan, Atike Pinar; Demirci, Umut; Yasar, Alper; Bayoglu, Ibrahim Vedat; Hizal, Mutlu; Gulbagci, Burcu; Paksoy, Nail; Davarci, Sena Ece; Yilmaz, Funda; Dogan, Ozlem; Orhan, Sibel Oyucu; Kayikcioglu, Erkan; Aytac, Ali; Keskinkilic, Merve; Mocan, Eda Eylemer; Unal, Olcun Umit; Aydin, Esra; Yucel, Hakan; Isik, Deniz; Eren, Onder; Uluc, Basak Oyan; Ozcelik, Melike; Hacibekiroglu, Ilhan; Aydiner, Adnan; Demir, Hacer; Oksuzoglu, Berna; Cilbir, Ebru; Cubukcu, Erdem; Cetin, Bulent; Oktay, Esin; Erol, Cihan; Okutur, Sadi Kerem; Yildirim, Nilgun; Alkan, Ali; Selcukbiricik, Fatih; Aksoy, Asude; Karakas, Yusuf; Ozkanli, Gulhan; Duman, Berna Bozkurt; Aydin, Dincer; Dulgar, Ozgecan; Er, Muhammed Muhiddin; Teker, Fatih; Yavuzsen, Tugba; Aykan, Musa Baris; Inal, Ali; Iriagac, Yakup; Kalkan, Nurhan Onal; Keser, Murat; Sakalar, Teoman; Menekse, Serkan; Kut, Engin; Bilgin, Burak; Karaoglanoglu, Muge; Sunar, Veli; Ozdemir, Ozlem; Turhal, Nazim Serdar; Karadurmus, Nuri; Yalcin, Bulent; Sendur, Mehmet Ali Nahit
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)

在CDK 4/6抑制剂治疗下疾病进展的激素阳性晚期乳腺癌患者中后续治疗的疗效 (第23卷，136，2023)

BMC CANCER
IF3.4
2023-02-272
OAAI
Karacin, Cengiz; Oksuzoglu, Berna; Demirci, Ayse; Keskinkilic, Merve; Baytemur, Naziyet Kose; Yilmaz, Funda; Selvi, Oguzhan; Erdem, Dilek; Avsar, Esin; Paksoy, Nail; Demir, Necla; Goksu, Sema Sezgin; Turker, Sema; Bayram, Ertugrul; Celebi, Abdussamet; Yilmaz, Hatice; Kuzu, Omer Faruk; Kahraman, Seda; Gokmen, Ivo; Sakin, Abdullah; Alkan, Ali; Nayir, Erdinc; Ugrakli, Muzafer; Acar, Omer; Erturk, Ismail; Demir, Hacer; Aslan, Ferit; Sonmez, Ozlem; Korkmaz, Taner; Celayir, Ozde Melisa; Karadag, Ibrahim; Kayikcioglu, Erkan; Sakalar, Teoman; Oktem, Ilker Nihat; Eren, Tulay; Erul, Enes; Mocan, Eda Eylemer; Kalkan, Ziya; Yildirim, Nilgun; Ergun, Yakup; Akagunduz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Demirel, Burcin Cakan; Karaboyun, Kubilay; Almuradova, Elvina; Unal, Olcun Umit; Oyman, Abdilkerim; Isik, Deniz; Okutur, Kerem; Oztosun, Bugra; Gulbagci, Burcu Belen; Kalender, Mehmet Emin; Sahin, Elif; Seyyar, Mustafa; Ozdemir, Ozlem; Selcukbiricik, Fatih; Kanitez, Metin; Dede, Isa; Gumus, Mahmut; Gokmen, Erhan; Yaren, Arzu; Menekse, Serkan; Ebinc, Senar; Aksoy, Sercan; Imamoglu, Goksen Inanc; Altinbas, Mustafa; Cetin, Bulent; Uluc, Basak Oyan; Er, Ozlem; Karadurmus, Nuri; Erdogan, Atike Pinar; Artac, Mehmet; Tanriverdi, Ozgur; Cicin, Irfan; Sendur, Mehmet Ali Nahit; Oktay, Esin; Bayoglu, Ibrahim Vedat; Paydas, Semra; Aydiner, Adnan; Salim, Derya Kivrak; Geredeli, Caglayan; Yavuzsen, Tugba; Dogan, Mutlu; Hacibekiroglu, Ilhan
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

在CDK 4/6抑制剂治疗下疾病进展的激素阳性晚期乳腺癌患者的后续治疗效果

BMC CANCER
IF3.4
2023-02-1016
OAAI
Karacin, Cengiz; Oksuzoglu, Berna; Demirci, Ayse; Keskinkilic, Merve; Baytemur, Naziyet Kose; Yilmaz, Funda; Selvi, Oguzhan; Erdem, Dilek; Avsar, Esin; Paksoy, Nail; Demir, Necla; Goksu, Sema Sezgin; Turker, Sema; Bayram, Ertugrul; Celebi, Abduessamet; Yilmaz, Hatice; Kuzu, Omer Faruk; Kahraman, Seda; Gokmen, Ivo; Sakin, Abdullah; Alkan, Ali; Nayir, Erdinc; Ugrakli, Muzaffer; Acar, Omer; Erturk, Ismail; Demir, Hacer; Aslan, Ferit; Sonmez, Ozlem; Korkmaz, Taner; Celayir, Ozde Melisa; Karadag, Ibrahim; Kayikcioglu, Erkan; Sakalar, Teoman; Oktem, Ilker Nihat; Eren, Tulay; Urul, Enes; Mocan, Eda Eylemer; Kalkan, Ziya; Yildirim, Nilgun; Ergun, Yakup; Akagunduz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Demirel, Burcin Cakan; Karaboyun, Kubilay; Almuradova, Elvina; Unal, Olcun Umit; Oyman, Abdilkerim; Isik, Deniz; Okutur, Kerem; Oztosun, Bugra; Gulbagci, Burcu Belen; Kalender, Mehmet Emin; Sahin, Elif; Seyyar, Mustafa; Ozdemir, Ozlem; Selcukbiricik, Fatih; Kanitez, Metin; Dede, Isa; Gumus, Mahmut; Gokmen, Erhan; Yaren, Arzu; Menekse, Serkan; Ebinc, Senar; Aksoy, Sercan; Imamoglu, Goksen Inanc; Altinbas, Mustafa; Cetin, Bulent; Uluc, Basak Oyan; Er, Ozlem; Karadurmus, Nuri; Erdogan, Atike Pinar; Artac, Mehmet; Tanriverdi, Ozgur; Cicin, Irfan; Sendur, Mehmet Ali Nahit; Oktay, Esin; Bayoglu, Ibrahim Vedat; Paydas, Semra; Aydiner, Adnan; Salim, Derya Kivrak; Geredeli, Caglayan; Yavuzsen, Tugba; Dogan, Mutlu; Hacibekiroglu, Ilhan
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study
BREAST
IF7.9
2022-12-0112
OAAI
Yildirim, Hasan Cagri; Mutlu, Emel; Chalabiyev, Elvin; Ozen, Mirac; Keskinkilic, Merve; On, Sercan; Celebi, Abdussamet; Dursun, Bengu; Acar, Omer; Kahraman, Seda; Aykan, Musa Baris; Kaman, Omur; Dogan, Akif; Erdogan, Atike Pinar; Celayir, Ozde Melisa; Gunenc, Damla; Guven, Deniz Can; Bayoglu, Ibrahim Vedat; Yavuzsen, Tugba; Hacibekiroglu, Ilhan; Inanc, Mevlude; Kilickap, Saadettin; Yalcin, Suayib; Aksoy, Sercan

研究方向

暂未获取到该数据
A
Abdüssamet Çelebi
H 指数:6论文数:46被引数:144
S
Selver Işık
H 指数:7论文数:71被引数:163
E
Erkam Kocaaslan
H 指数:3论文数:43被引数:30
Y
Yeşim Ağyol
H 指数:3论文数:35被引数:31
M
Mustafa Alperen Tunç
H 指数:2论文数:23被引数:20
M
Murat Sarı
H 指数:16论文数:144被引数:726
N
Nargız Majidova
H 指数:6论文数:77被引数:104
A
Ali Kaan Güren
H 指数:4论文数:49被引数:44
İ
İlhan Hacıbekiroğlu
H 指数:13论文数:133被引数:1,133
P
Pınar Erel
H 指数:3论文数:34被引数:33